Avinger, Inc.

The momentum for this stock is not very good. Avinger, Inc. has good growth characteristics. Avinger, Inc. is not very popular among insiders. Avinger, Inc. is a mediocre stock to choose.

Avinger, Inc. is a commercial-stage medical device company. The firm designs, manufactures and sells...

News

Avinger announces commercial launch of Pantheris LV atherectomy device

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device

Accesswire REDWOOD CITY, CA / ACCESSWIRE / August 20, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...\n more…

Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript

Seeking Alpha: Transcripts Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript...\n more…

AVGR Stock Earnings: Avinger Misses EPS, Misses Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nAVGR stock results show that Avinger missed analyst estimates for earnings per share and missed on revenue for the second quarter of...\n more…

Avinger reports Q2 results

SeekingAlpha.com: All News Avinger (AVGR) reports Q2 revenue of $1.8M, missing expectations by $0.75M.\n more…

Avinger (AVGR) Reports Q2 Loss, Lags Revenue Estimates

Zacks Investment Research Avinger (AVGR) came out with a quarterly loss of $2.82 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $8.85 per share a year ago. These figures are...\n more…